In the Spotlight

Perceval ‘size XL’ expands the number of patients that can benefit from a sutureless aortic valve replacement Milan, Italy, November 22, 2013 - Sorin Group, (Reuters Code: SORN.MI), a global medical company and a leader in the treatment of cardiovascular diseases, announced today ...+
More than 100,000 Mitroflow® Aortic Pericardial Heart Valves Implanted Worldwide. Milan, Italy. February 21, 2011 – Sorin Group, (Reuters CodeSORN.MI), a global medical device company and a leader in the treatment of cardiovascular diseases, announced a major ...+
Sorin’s Mitroflow Valsalva Conduit allows for safer device manipulation during assembly and implantation, thus limiting cardiac surgery time Milan, Italy, November 6, 2012 – Sorin Group, (Reuters Code: SORN.MI), a global medical device company and a leader in the treatment of ...+
Mitroflow, the bioprosthesis that features proven clinical results1, 2, 3 Milan, Italy, December 4, 2012 – Sorin Group, (Reuters Code: SORN.MI) a global medical company and a leader in the treatment of cardiovascular diseases, announced today that it received the Japanese ...+

News

Events